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Abstract
Objectives—To evaluate specific medications and patient characteristics as risk factors for 
falling in the hospital.
Methods—Case-control study comparing demographic, health, mobility, and medication data for 
228 patients who fell between 6/29/2007 and 11/14/2007 at a large tertiary care hospital and 690 
randomly-selected control patients. Logistic regression was used to identify fall risk factors.
Results—Independent risk factors for falling included: history of falls (OR, 2.7; 95% CI, 1.8 – 
4.2); needing an assistive device (OR, 3.2; 95% CI, 1.5 – 6.8) or person assistance (OR, 2.1; 95% 
CI, 1.3 – 3.3) to ambulate; being underweight (OR, 2.4; 95% CI, 1.2 – 4.7) or obese (OR, 1.6; 
95% CI, 1.0 – 2.5); confusion (OR, 2.4; 95% CI, 1.5 – 4.0); dizziness (OR, 2.1; 95% CI, 1.1 – 
4.3); incontinence (OR, 1.5; 95% CI, 1.0 – 2.3); and an order for a hydantoin (OR, 3.3; 95% CI, 
1.3 – 8.0) or benzodiazepine anticonvulsant (OR, 2.2; 95% CI, 1.5 – 3.3), haloperidol (OR, 2.8; 
95% CI, 1.2 – 6.8), tricyclic antidepressant (OR, 2.4; 95% CI, 1.2 – 4.9) or insulin (OR, 1.5; 95% 
CI, 1.0 – 2.1). Female gender (OR, 0.8; 95% CI, 0.6–1.0), proton pump inhibitors (OR, 0.6; 95% 
CI, 0.4 – 0.9), and muscle relaxants (OR, 0.4; 95% CI, 0.3 – 0.7) were associated with lower risk 
of falling.
Conclusions—This study identified medications and patient characteristics associated with 
increased risk for falling in the hospital. High-risk medications identified in this study may serve 
as targets for medication review or adjustment, which have been recommended as a component of 
multifaceted fall prevention programs.
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INTRODUCTION
Falls are common adverse events in hospitals and can result in significant injuries. Reported 
fall rates for hospital inpatients range from 1.7 to 25 falls per 1,000 patient days, depending 
on the patient care area, with 6%–44% resulting in injury1. Injurious falls are associated 
with increased healthcare costs, longer hospital stays, and greater likelihood of discharge to 
a nursing home or rehabilitation facility2, 3. Medication review has been recommended as 
part of multifaceted fall prevention programs for hospital inpatients4, 5. However, guidelines 
for how to assess medication risk or specifying which medications should be targeted are 
limited.
Several medications have been reported to increase the risk for falling in the hospital, most 
commonly sedatives/hypnotics, benzodiazepines, and psychotropics6–8. Other medications, 
including antiepileptics, anticholinergics, beta blockers, and antidiabetic agents, have been 
inconsistently associated with fall risk6, 9. Although prior studies have evaluated medications 
as risk factors for falling, most have focused on broad medication classes rather than specific 
types of drugs and few studies have evaluated the effect of newly prescribed versus long 
term medications on fall risk. This lack of detail makes it difficult to develop an effective, 
comprehensive, and predictive view of a patient’s fall risk and hinders the development of 
medication review interventions, which are a recommended part of comprehensive fall 
prevention strategies.
To provide more detailed information about the association between medications and falling 
in the hospital, we conducted a case-control study of patients who fell at a large teaching 
hospital. The objective of this study was to identify specific medications and patient 
demographic and health characteristics associated with falls and to evaluate the impact of 
multiple high-risk medications and newly prescribed medications on fall risk.
METHODS
Study Population
This study was conducted at Barnes-Jewish Hospital (BJH), a 1,074-bed urban tertiary care 
hospital affiliated with Washington University School of Medicine. In 2007, BJH had 1,036 
reported falls and a fall rate of 3.50 per 1,000 patient days. The study included all inpatient 
falls reported to the hospital’s safety event reporting system between June 29 and November 
14, 2007.
The BJH safety event reporting system defines a fall as a sudden and unplanned descent 
from a standing, sitting, or horizontal position to the floor or an extension of the floor. This 
definition includes falls related to physiologic events and falls in which the patient is assisted 
to the floor by staff or a visitor. Inpatients age 21 and older admitted to medicine, surgery, 
step down, and critical care services were eligible for inclusion in this study. Patients in the 
emergency room or on the obstetrics service were excluded because risk factors for falls in 
these units differ from risk factors for falls among the general hospital population. Oncology 
and psychiatry patients were excluded due to their unique comorbidities and medications 
which may impact fall risk. Falls that occurred during physical therapy sessions were 
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excluded because these sessions encourage activities that can cause postural instability and 
may result in the patient being lowered to the floor by a physical therapist to prevent injury.
Two hundred and fifty fall events were prospectively identified for inclusion in the study 
using fall safety event reports. Fall reports were cross-referenced to identify patients who 
fell multiple times during their admission; only the first falls were included in the analysis10. 
For each patient who fell, three control patients who were in the hospital during the same 
period of time but did not fall were identified using the hospital’s informatics database. 
Controls were randomly selected from among patients who were admitted within three days 
of the index case and discharged after the date of the fall. For six cases with particularly long 
admissions, controls meeting these criteria could not be identified and patients admitted 
more than three days after the case patient were selected.
The study protocol was reviewed and approved by the Washington University Human 
Research Protection Office. The need for written informed consent was waived because the 
study used preexisting data and posed no additional risk to patients.
Data Sources
Patient demographic data, including age, gender, and body mass index (BMI) was obtained 
from the hospital informatics database. Data on history of falls, mobility, ability to estimate 
the time (a measure of confusion), whether the patient overestimated his/her abilities (based 
on nurse observations), urinary/stool frequency or incontinence, and presence of neuropathy, 
syncope/fainting, or dizziness/orthostatic hypotension prior to the fall were abstracted from 
electronic medical records. Details about fall events, including fall location, whether the fall 
was assisted, and any resulting injuries, were collected from fall safety event reports. Data 
on all active medication orders from the four days prior to the fall were obtained from the 
hospital pharmacy database. Medications taken prior to admission were identified by 
comparing hospital drug orders to a list of home medications recorded in the patient’s 
admission assessment according to the Joint Commission’s Medication reconciliation 
guidance for hospitals. Medications were considered “new” if first prescribed during the 
hospitalization and “continued” if taken prior to admission.
Statistical Analysis
Data abstracted from patient medical records were double-entered into Microsoft Access 
(Redmond, WA), cleaned, and merged with the data from electronic medical records. All 
statistical analysis was performed using IBM SPSS Statistics, version 16.0 (IBM Inc., 
Armonk, NY). Logistic regression was used to calculate crude odds ratios (ORs) and 95% 
confidence intervals (CIs) for potential fall risk factors. Medications ordered for fewer than 
five cases or control patients were excluded from the analysis due to low cell counts. A 
multivariable model was then developed using a manual stepwise method and inputting 
variables with univariate p-values <0.10. Abnormal gait and having a fall as the reason for 
admission were not included in the multivariable analysis due to colinearity with ambulation 
and history of falls, respectively. Patients with missing data for any of the variables included 
in the multivariable model were also excluded from the multivariable analysis. Variables 
with a p-value <0.05 in multivariable analysis were retained in the final model. Two-way 
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interaction terms for the medications included in the final model were assessed to test for 
effect modification. Adequacy of the model was assessed using the Hosmer-Lemeshow 
goodness of fit test.
Additional analyses were conducted to provide further information about the medications 
identified as risk factors in the multivariable model. Multivariable analyses were conducted 
to determine whether patients prescribed multiple high risk medications were at greater risk 
for falls than others, while controlling for the patient characteristics associated with falls in 
the multivariable model. Fisher’s exact tests were used to determine whether new 
medication orders were associated with greater risk for falling in the hospital than 
medications taken prior to admission.
RESULTS
Fall Circumstances and Outcomes
From the 250 fall events reported during the study period, 226 first falls were identified. 
These cases and the corresponding 678 controls were included in the analysis. Falls were 
equally distributed during day (48.7%) and night (51.3%) shifts. Although most falls 
(81.0%) were unassisted, 14.1% of patients who fell were assisted to the floor by an 
employee and 4.9% were assisted by a visitor. Common fall circumstances included: falls 
from bed (37.2%); falls while ambulating (23.5%); falls from a standing position (11.9%); 
falls from a chair (8.0%); and falls from a bedside commode (8.4%) or toilet (4.0%). Only 
9.7% of patients who fell had asked for assistance prior to the fall. Environmental hazards 
that contributed to falls included: rolling equipment (7.5%); having a needed item out of 
reach (6.2%); inappropriate footwear (4.0%); slippery floors (3.5%); and trip hazards or 
clutter (1.3%). Approximately 38% of falls were related to the patient’s need for toileting.
Of the patients who fell, 161 (71.2%) were not injured. Fifty two patients (23.0%) sustained 
minor injuries, such as abrasions or bruising, three (1.3%) sustained moderate injury, and 
three (1.3%) sustained major injury. Moderate injuries included damaged teeth (2 patients) 
and facial swelling/bleeding. Major injuries included a maxillary sinus fracture, a pelvic 
fracture, and a subdural hematoma. Mean length of stay was similar for patients who fell 
(11.3 days) and controls (11.4 days), p = 0.903.
Univariate Analysis
Table 1 presents demographic, mobility, and health data for patients who fell and controls. 
Variables with univariate p-values <0.10 included gender, being underweight (BMI < 18.5 
kg/m2), history of falls during the past three months or as the reason for hospital admission, 
weak or impaired gait, needing an assistive device or person assistance to ambulate, 
incontinence, syncope, dizziness, over-estimating ability, and providing an incorrect time 
estimate (confusion).
Medication data for case and control patients are presented in Table 2. Medications in this 
table are organized according to the Cerner Multum drug classification system 
(www.multum.com), which is how drug order data is coded at our institution. The Multum 
drug classification system organizes medications into categories and subcategories by type. 
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Certain medications, such as benzodiazepines, may be classified under different categories 
depending on how they are ordered, although a single medication order can only have one 
classification to avoid redundancy. The Multum system thus provides information not only 
about the specific drug that was ordered, but also about its intended application. This 
allowed for a detailed analysis of the association between specific medications and 
medication categories and risk for falling in the hospital.
Medications associated with falling (p <0.10) included centrally acting antiadrenergic agents 
(clonidine and methyldopa), benzodiazepine anticonvulsants (lorazepam, diazepam, 
clonazepam), hydantoin anticonvulsants (phenytoin), antidiarrheals (loperamide), insulin, 
tricyclic antidepressants (amitriptyline, nortriptyline, clomipramine, doxepin, desipramine), 
phenylpiperazine antidepressants, and haloperidol. Antiarrhythmics, potassium-sparing 
diuretics, vasopressors, narcotic analgesic combinations, NSAIDs, 5HT3 receptor 
antagonists, anticholinergic antiemetics, anticholinergic antiparkinson agents, ‘other’ 
anxiolytics/sedatives (diphenhydramine and zolpidem), general anesthetics, muscle 
relaxants, antacids, proton pump inhibitors, antihistamines, and decongestants were 
associated with reduced risk.
Multivariate Analysis
The final multivariable model is presented in Table 3. There were 887 patients included in 
the final model after data for 17 patients who were missing data for one or more of the 
included variables were excluded from the analysis. History of falls (aOR, 2.73; 95% CI, 
1.79 – 4.16), needing an assistive device (aOR, 3.17; 95% CI, 1.47 – 6.80) or person 
assistance (aOR, 2.08; 95% CI, 1.31 – 3.31) to ambulate, being underweight (aOR, 2.35; 
95% CI, 1.17 – 4.74) or obese (aOR, 1.58; 95% CI, 1.01 – 2.48), confusion/incorrect time 
estimate (aOR, 2.44; 95% CI, 1.48 – 4.03), dizziness (aOR; 2.12, 95% CI, 1.05 – 4.28), and 
incontinence, (aOR, 1.53; 95% CI, 1.00 – 2.33) were identified as independent risk factors 
for falling. Medications associated with increased risk for falling included hydantoin 
anticonvulsants (aOR, 3.25; 95% CI, 1.33 – 7.95), benzodiazepine anticonvulsants (aOR, 
2.19; 95% CI, 1.46 – 3.29), haloperidol (aOR, 2.80; 95% CI, 1.16 – 6.77), tricyclic 
antidepressants (aOR, 2.43; 95% CI, 1.21 – 4.90) and insulin (aOR, 1.46; 95% CI, 1.01 – 
2.13). Female gender (aOR, 0.69, 95% CI, 0.48 – 0.98) and an order for a proton pump 
inhibitor (aOR, 0.63; 95% CI, 0.44 – 0.90) or muscle relaxant (aOR, 0.44; 95% CI, 0.27 – 
0.71) were associated with reduced risk of falling. The Hosmer-Lemeshow goodness of fit 
test showed adequacy of the model (p=.574). No two-way interaction terms for medications 
included in the final model were statistically significant.
Additional Analyses
Results of the analysis to determine the effect of having orders for more than one of the 
high-risk medications identified in the multivariable model is presented in Table 4. A dose-
response effect was observed between the number of high-risk medications and falls. 
Patients prescribed two high-risk medications were 3.4 times more likely to fall during their 
hospital stay than patients on no high risk medications and patients with orders for three or 
more high-risk medications were 11.8 times more likely to fall.
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In the analysis to determine whether new medication orders were associated with greater 
risk than medications continued from home, there was no statistical difference in the 
proportion of new orders for cases versus controls in any of the high-risk medication 
categories (Fisher’s Exact test p-values: 0.48 for haloperidol; 0.61 for benzodiazepine 
anticonvulsants; and 1.00 for hydantoin anticonvulsants, tricyclic antidepressants, and 
insulin). However, this analysis may have been limited by potentially incomplete 
information regarding medications used prior to hospital admission and small numbers.
DISCUSSION
Multiple factors contribute to risk for falling in the hospital, including intrinsic patient risk 
factors, medications, and environmental hazards. The patient characteristics identified as risk 
factors in this study are generally consistent with risk factors previously identified in the 
literature. Female gender was associated with reduced likelihood of falls in our study, 
consistent with previous studies which have shown that males are at increased risk for falling 
in the hospital11–13. Prior studies have also identified history of falls 6, 7, need for 
ambulatory assistance14, 15, confusion3, 7, 12, 16, dizziness12, 17 and incontinence 3, 12, 18 as 
fall risk factors. Although older age is generally considered to be an important fall risk 
factor3, 19, age was not associated with falls in our study. However, evidence for an 
association between older age and falls in acute care settings is inconsistent1 and may be 
related to an association between age and physical changes that increase fall risk20.
We could find no prior studies in the literature that report an association between patient 
BMI and risk for falling in the hospital. However, studies of community-dwelling adults 
have identified an association between being underweight or obese and risk for injurious 
falls21, 22. Underweight patients may be at increased risk due to frailty23, 24. Obese patients 
may be at risk if they do not exercise regularly15, have multiple comorbidities1, 15, 25, or 
have difficulty navigating a hospital room. Additional studies are needed to further 
investigate the association between BMI and fall risk.
Most of the medications identified as risk factors in this study have also been previously 
identified in the literature. Several studies have reported an association between 
anticonvulsants and risk for falling in the hospital6, although few have examined specific 
types of anticonvulsants in relation to falls. Only hydantoin and benzodiazepine 
anticonvulsants were identified as independent risk factors for falling in this study. 
Benzodiazepines are known to be associated with increased risk of falling26–28 and 
lorazepam and diazepam have been specifically identified as risk factors for falls in hospital 
patients28; however, only one prior study has reported an association between hydantoins 
and falls29. Antidepressants are also known to increase risk for falling in the hospital28, 30, 31 
and tricyclic antidepressants have been identified as a risk factor for falls in community and 
nursing home settings32, 33.
This study is among the first to report an association between haloperidol or insulin and 
falls. We could find only one study reporting an association between haloperidol and 
hospital falls28, although antipsychotics, in general, are a frequently identified risk factor31. 
Prior studies have reported an association between antidiabetic medications and risk for 
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falling in the hospital but have not identified insulin, specifically, as a risk factor16, 27. 
Insulin was the only antidiabetic medication associated with falls in our study, a finding that 
is supported by a systematic review which found that insulin, but not other antidiabetic 
medications, increases fall risk34.
Two types of medications were associated with reduced risk for falling in the multivariable 
model: proton pump inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, 
rabeprazole) and muscle relaxants (vercuronium, succinylcholine, rocuronium, 
cyclobenzaprine, baclofen, and atracurium). An association between proton pump inhibitors 
and falls has not been previously reported and the reason for this association is unclear. An 
association between muscle relaxants and falls has also not been reported, but is likely 
related to the fact that patients taking muscle relaxants are generally sedated or medically 
paralyzed ICU patients who are relatively immobile and therefore, unlikely to fall.
While an order for a hydantoin anticonvulsant, benzodiazepine anticonvulsant, haloperidol, 
tricyclic antidepressant, or insulin was associated with increased risk for falling when taken 
alone, the risk of falling was more pronounced in patients with orders for more than one of 
these medications. Polypharmacy, especially involving high-risk medications, has been 
consistently identified as a risk factor for falling in the hospital6, 9. These findings suggest 
that patients with orders for multiple high-risk medications should be placed on fall 
precautions and alternative medication regimens considered, when possible. Although we 
found no statistical difference in the proportion of new medication orders for patients who 
fell versus controls, further study is warranted, as small numbers and potentially incomplete 
home medication records may have limited this analysis.
Strengths of this study include prospective data collection, detailed evaluation of 
medications, use of multivariable analysis, and a relatively large sample size. Limitations 
include the matching of cases and controls only on date of admission and data limitations, 
including inconsistencies in fall risk assessments, fall reports completed by staff who may 
not have witnessed the fall, and medication data derived from pharmacy orders rather than 
drug administration records. As a single institution study, our results may also not be 
broadly generalizable. Additional studies that make use of more robust data and statistical 
techniques will be needed to validate the associations identified in this study and to evaluate 
the impact of patient diagnosis and comorbidity on these associations. Additional research is 
also needed to identify risk factors for falls in groups excluded in this analysis, such as 
oncology and psychiatry patients. Large multicenter data sets will be needed to examine 
infrequently prescribed medications and allow for greater generalizability of study results.
CONCLUSION
This study identified medications and patient characteristics associated with falls in a 
hospital setting and examined the impact of multiple high-risk medications on risk for 
falling. The results provide further evidence for an association between certain medications 
and risk for falling in the hospital, with risk being more pronounced in patients prescribed 
more than one high-risk medication. Supplementing existing fall risk assessment and 
prevention tools with medication review targeting these high-risk medications may allow for 
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better identification of patients at risk for falling during their hospital admission and help to 
reduce the incidence of patient falls. High risk medications should be avoided, when 
possible, especially for patients who are already at high risk for falls or injury. The 
accumulating evidence for an association between certain medications and risk for falling, 
and the importance of falls as a public health and hospital safety problem, also suggests that 
it may be beneficial to routinely evaluate the potential effect of new medications on fall risk 
during the drug approval process.
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Table 1
Results of the Univariate Analysis of Patient Characteristics as Risk Factors for Falls
Characteristic
Cases
n = 226 (%)
Controls
n = 678 (%) OR (95% CI)
Gender (female) 103 (45.6) 355 (52.4) 0.76 (0.56 – 1.03)
Age, mean (SD) 61.5 (15.5) 59.7 (17.4) 1.01 (0.99 – 1.02)
BMI
 Normal (18.5 – 24.9) 61 (26.9) 222 (32.7) 1[Reference]
 Underweight (≤18.5) 22 (9.7) 31 (4.6) 2.58 (1.40 – 4.78)
 Overweight (25.0 – 29.9) 68 (30.1) 197 (29.1) 1.26 (0.85 – 1.87)
 Obese (≥30) 73 (32.3) 218 (32.3) 1.22 (0.83 – 1.80)
History of falls 75 (33.2) 76 (11.2) 3.93 (2.73 – 5.67)
Fall was reason for admission 15 (6.6) 18 (2.7) 2.65 (1.31 – 5.34)
Gait
 Normal 28 (12.4) 186 (27.4) 1[Reference]
 Weak or impaired 160 (70.8) 350 (51.6) 1.49 (1.21 – 1.83)
 Unable to assess 38 (16.8) 142 (20.9) 1.78 (1.04 – 3.04)
Ambulation
 No assistance needed 36 (15.9) 230 (33.9) 1[Reference]
 Bedrest 43 (19.0) 148 (21.8) 1.86 (1.14 – 3.03)
 Assistive device 16 (7.1) 34 (5.0) 3.01 (1.51 – 6.00)
 Person assistance 131 (58.0) 266 (39.2) 3.15 (2.09 – 4.74)
Incontinence 61 (27.0) 108 (15.9) 1.95 (1.36 – 2.79)
Urinary catheter 77 (34.1) 242 (35.7) 0.93 (0.68 – 1.27)
Hearing impairmenta 13 (5.8) 29 (4.3) 1.40 (0.71 – 2.75)
Glassesb 114 (50.4) 330 (48.7) 1.17 (0.83 – 1.66)
Neuropathy 8 (3.5) 30 (4.4) 0.80 (0.36 – 1.76)
Syncope 14 (6.2) 20 (2.9) 2.17 (1.08 – 4.38)
Dizziness 20 (8.8) 29 (4.3) 2.17 (1.20 – 3.92)
Overestimates ability 73 (32.3) 99 (14.7) 2.77 (1.95 – 3.93)
Estimate of the time (confusion)
 Correct 146 (64.6) 554 (81.7) 1[Reference]
 Incorrect 55 (24.3) 52 (7.7) 4.01 (2.64 – 6.11)
 Unable to answer 25 (10.6) 69 (10.2) 1.32 (0.80 – 2.17)
High risk for fallsc 143 (63.3) 284 (41.9) 2.39 (1.75 – 3.26)
Abbreviations: OR, odds ratio; CI, confidence interval
a
Data was missing for 42 (18.6%) cases and 116 (17.1%) controls.
b
Data was missing for 44 (19.5%) cases and 117 (17.3%) controls.
c
Risk determined by a nursing falls risk assessment that evaluated history of falls, weak or impaired gait, need for assistance with ambulation, 
overestimating one’s ability, and inability to correctly estimate the time. Risk was considered “low” if the patient had less than three affirmative 
answers and “high” if the patient had three or more.
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Table 2
Results of the Univariate Analysis of Medications as Risk Factors for Falls
Medication
Cases
n = 226 (%)
Controls
n = 678 (%) OR (95% CI)
Cardiovascular Agents 168 (74.3) 540 (79.6) 0.74 (0.52 – 1.05)
 ACE inhibitors 46 (20.4) 143 (21.1) 0.96 (0.66 – 1.39)
 Angiotensin II inhibitors 10 (4.4) 34 (5.0) 0.88 (0.43 – 1.8)
 Antiadrenergic agents, centrally acting 17 (7.5) 28 (4.1) 1.89 (1.01 – 3.52)
 Antiadrenergic agents, peripherally acting 13 (5.8) 30 (4.4) 1.32 (0.68 – 2.57)
 Antianginal agents 32 (14.2) 92 (13.6) 1.05 (0.68 – 1.62)
 Antiarrhythmics 45 (19.9) 200 (29.5) 0.59 (0.41 – 0.86)
 Beta blockers 114 (50.4) 324 (47.8) 1.11 (0.82 – 1.50)
 Calcium channel blockers 36 (15.9) 141 (20.8) 0.72 (0.48 – 1.08)
 Diuretics 83 (36.7) 224 (33.0) 1.18 (0.86 – 1.61)
  Loop diuretics 71 (31.4) 180 (26.5) 1.27 (0.91 – 1.76)
  Potassium-sparing diuretics 7 (3.1) 42 (6.2) 0.48 (0.21 – 1.09)
  Thiazide diuretics 19 (8.4) 42 (6.2) 1.39 (0.79 – 2.44)
 Inotropic agents 19 (8.4) 70 (10.3) 0.80 (0.47 – 1.36)
 Vasodilators 48 (21.2) 143 (21.1) 1.01 (0.70 – 1.46)
 Vasopressors 34 (15.0) 164 (24.2) 0.56 (0.37 – 0.83)
Central Nervous System Agents 222 (98.2) 664 (97.9) 1.17 (0.38 – 3.59)
 Analgesics 216 (95.6) 644 (95.0) 1.14 (0.55 – 2.35)
  Narcotics 131 (58.0) 425 (62.7) 0.82 (0.60 – 1.12)
  Narcotic combinations 81 (35.8) 304 (44.8) 0.69 (0.50 – 0.94)
  NSAIDs 18 (8.0) 85 (12.5) 0.60 (0.35 – 1.03)
  Salicylates 83 (36.7) 219 (32.3) 1.22 (0.89 – 1.67)
 Anticonvulsants 126 (55.8) 270 (39.8) 1.90 (1.41 – 2.58)
  Benzodiazepines 76 (33.6) 109 (16.1) 2.65 (1.88 – 3.73)
  Hydantoins 17 (7.5) 11 (1.6) 4.93 (2.27 – 10.70)
  Othera 51 (22.6) 129 (19.0) 1.24 (0.86 – 1.79)
 Antiemetic/antivertigo agents 146 (64.6) 489 (72.1) 0.71 (0.51 – 0.97)
  5HT3 receptor antagonists 95 (42.0) 368 (54.3) 0.61 (0.45 – 0.83)
  Anticholinergics 47 (20.8) 198 (29.2) 0.64 (0.44 – 0.91)
  Phenothiazines 45 (19.9) 139 (20.5) 0.96 (0.66 – 1.40)
  Otherb 34 (15.0) 98 (14.5) 1.05 (0.69 – 1.60)
 Antiparkinson agents 56 (24.8) 207 (30.5) 0.75 (0.53 – 1.06)
  Anticholinergics 48 (21.2) 193 (28.5) 0.68 (0.47 – 0.97)
  Dopaminergics 9 (4.0) 18 (2.7) 1.52 (0.67 – 3.44)
 Anxiolytics, sedatives, and hypnotics 145 (64.2) 433 (63.9) 1.01 (0.74 – 1.39)
  Benzodiazepines 115 (50.9) 305 (45.0) 1.27 (0.94 – 1.71)
  Otherc 76 (33.6) 281 (41.4) 0.72 (0.52 – 0.98)
 General anesthetics 39 (17.3) 190 (28.0) 0.54 (0.37 – 0.79)
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Medication
Cases
n = 226 (%)
Controls
n = 678 (%) OR (95% CI)
 Muscle relaxants 28 (12.4) 168 (24.8) 0.43 (0.28 – 0.66)
Coagulation Modifiers 180 (79.6) 551 (81.3) 0.90 (0.92 – 1.32)
 Anticoagulants 164 (72.6) 503 (74.2) 0.92 (0.66 – 1.29)
 Antiplatelet agents 87 (38.5) 233 (34.4) 1.20 (0.88 – 1.63)
 Thrombolytics 10 (4.4) 24 (3.5) 1.26 (0.59 – 2.68)
Gastrointestinal Agents 203 (89.8) 625 (92.2) 0.75 (0.45 – 1.25)
 Antacids 71 (31.4) 271 (40.0) 0.69 (0.50 – 0.95)
 Anticholinergics/antispasmodics 10 (4.4) 47 (6.9) 0.62 (0.31 – 1.25)
 Antidiarrheals 10 (4.4) 13 (1.9) 2.37 (1.02 – 5.48)
 GI stimulants 33 (14.6) 87 (12.8) 1.16 (0.75 – 1.79)
 H2 antagonists 46 (20.4) 124 (18.3) 1.14 (0.78 – 1.67)
 Laxatives 159 (70.4) 501 (73.9) 0.84 (0.60 – 1.17)
 Proton pump inhibitors 105 (46.5) 363 (53.5) 0.75 (0.56 – 1.02)
Hormones 110 (48.7) 300 (44.2) 1.20 (0.88 – 1.62)
 Adrenal cortical steroids 45 (19.9) 145 (21.4) 0.91 (0.63 – 1.33)
 Sex hormones 8 (3.5) 20 (2.9) 1.21 (0.52 – 2.78)
 Otherd 40 (17.7) 92 (13.6) 1.37 (0.91 – 2.06)
Antidiabetic Agents 85 (37.6) 217 (32.0) 1.28 (0.94 – 1.75)
 Insulin 82 (36.3) 203 (29.9) 1.33 (0.97 – 1.83)
 Sulfonylureas 7 (3.1) 17 (2.5) 1.24 (0.51 – 3.04)
Psychotherapeutic Agents 111 (49.1) 265 (39.1) 1.50 (1.11 – 2.04)
 Antidepressants 73 (32.3) 175 (25.8) 1.37 (0.98 – 1.90)
  Phenylpiperazines 10 (4.4) 14 (2.1) 2.20 (0.96 – 5.02)
  SSNRIs 13 (5.8) 32 (4.7) 1.23 (0.64 – 2.39)
  SSRIs 40 (17.7) 103 (15.2) 1.20 (0.80 – 1.79)
  Tetracyclics 7 (3.1) 17 (2.5) 1.24 (0.51 – 3.04)
  Tricyclics 18 (8.0) 29 (4.3) 1.94 (1.05 – 3.56)
 Antipsychotics 64 (28.3) 141 (20.8) 1.51 (1.07 – 2.12)
  Haloperidol 14 (6.2) 14 (2.1) 3.13 (1.47 – 6.68)
  Phenothiazines 37 (16.4) 104 (15.3) 1.08 (0.82 – 1.63)
Respiratory Agents 127 (56.2) 466 (68.7) 0.58 (0.43 – 0.80)
 Antihistamines 59 (26.1) 240 (35.4) 0.65 (0.46 – 0.90)
 Bronchodilators 66 (29.2) 199 (29.4) 0.99 (0.71 – 1.38)
 Decongestants 23 (10.2) 122 (18.0) 0.52 (0.32 – 0.83)
 Respiratory inhalants 13 (5.8) 43 (6.3) 0.90 (0.48 – 1.71)
Abbreviations: OR, odds ratio; CI, confidence interval
a
Includes magnesium sulfate, gabapentin, levetiracetam, divalproex, pregabalin, topiramate, acetazolamide, lamotrigine, primidone, and valproic 
acid.
b
Includes metoclopramide, lorazepam and dronabinol.
c
Includes diphenhydramine, zolpidem, hydroxyzine, dexmedetomidine, ramelteon, buspirone, eszopiclone, doxepin and zaleplon.
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d
Includes glucagon, desmopressin, vasopressin, octreotide, calcitonin and raloxifene.
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Table 3
Multivariate Model of Patient Characteristics and Medications Associated with Falls
aOR (95% CI)
Patient Characteristics
 Gender (female) 0.69 (0.48 – 0.98)
 History of falls 2.73 (1.79 – 4.16)
 Ambulation
  No assistance needed 1 [Reference]
  Bedrest 1.32 (0.72 – 2.42)
  Assistive device 3.17 (1.47 – 6.80)
  Person assistance 2.08 (1.31 – 3.31)
 Body Mass Index
  Normal (18.5 – 24.9) 1 [Reference]
  Underweight (≤18.5) 2.35 (1.17 – 4.74)
  Overweight (25.0 – 29.9) 1.44 (0.92 – 2.25)
  Obese (≥30) 1.58 (1.01 – 2.48)
 Estimate of the time (confusion)
  Correct 1 [Reference]
  Incorrect 2.44 (1.48 – 4.03)
  Unable to answer 0.94 (0.49 – 1.78)
 Dizziness 2.12 (1.05 – 4.28)
 Incontinence 1.53 (1.00 – 2.33)
Medications
 Hydantoin anticonvulsants 3.25 (1.33 – 7.95)
 Haloperidol 2.80 (1.16 – 6.77)
 Tricyclic antidepressants 2.43 (1.21 – 4.90)
 Benzodiazepine anticonvulsants 2.19 (1.46 – 3.29)
 Insulin 1.46 (1.01 – 2.13)
 Proton pump inhibitors 0.63 (0.44 – 0.90)
 Muscle relaxants 0.44 (0.27 – 0.71)
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval Hosmer-Lemeshow goodness of fit test: chi-square =6.66; p=.57
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Table 4
Comparison of the Number of High-Risk Medication Categories for Cases and Controls.
Number high-risk medications
Cases
n = 226 (%)
Controls
n=678 (%) aORa (95% CI)
 0 81 (35.8) 380 (56.0) 1 [Reference]
 1 93 (41.2) 234 (34.5) 1.55 (1.07 – 2.26)
 2 43 (19.0) 60 (8.8) 3.39 (2.03 – 5.67)
 3 – 4 9 (4.0) 4 (0.6) 11.82 (3.24 – 43.16)
Abbreviations: aOR, adusted odds ratio
aOdds ratios were adjusted for the following patient characteristics, which were significantly associated with falls in the multivarible model: 
gender, fall history, ambulation, BMI, ability to estimate the time, dizziness, and incontinence).
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